StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
UPDATE: Cowen Upgrades Sarepta Therapeutic (SRPT) to Outperform
September 20, 2016 6:41 AM
(Updated - September 20, 2016 8:48 AM EDT)
Cowen upgraded Sarepta Therapeutic (NASDAQ: SRPT) from Market Perform to Outperform ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Upgrades
Next Articles
Sarepta Therapeutics (SRPT) Shares on Watch Amid Chatter of Secondary Stock Offering
September 20, 2016 3:09 PM
Sarepta (SRPT) Wins Key PTO Decision on Composition of Matter Patents - Oppenheimer
September 20, 2016 1:18 PM
Sarepta Therapeutic (SRPT) PT Raised to $66 at Wedbush
September 20, 2016 7:21 AM
FDA Approves Sarepta Therapeutics' (SRPT) Eteplirsen
September 19, 2016 9:52 AM
Sarepta Therapeutics (SRPT) Granted FDA Accelerated Approval for Eteplirsen
September 19, 2016 9:51 AM